Chronic Obstructive Pulmonary Disease Treatment Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2027

 


The Chronic Obstructive Pulmonary Disease (COPD) market is expected to show substantial growth over the forecast period. As per Market Research Future (MRFR) analysis, the market for chronic obstructive pulmonary disease (COPD) was valued at approximately USD 10.7 billion in 2018 and is projected to register 4.2% of CAGR by 2025.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory pulmonary disease that causes obstructed airflow from the lungs. Its symptoms include breathing difficulties, coughing, mucus production, and wheezing. People with COPD are at increased risk of developing heart disease, lung cancer, and several other health conditions.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1612

Market Dynamics

The key factor driving the growth of the global market for chronic obstructive pulmonary disease (COPD) market is the growing prevalence of the chronic obstructive pulmonary disease worldwide, which is expected to fuel demand for chronic obstructive pulmonary disease (COPD) drugs. For example, AS per WHO, Global Burden of Disease Study estimates a global prevalence of 251 million cases of COPD in 2016. It is estimated that COPD will become the world's third leading cause of death by 2030. Additionally, the rising geriatric population and increasing customer understanding of the new and innovative treatment options also complement market growth. Through research and development in this field to develop more innovative COPD treatment solutions may also give numerous opportunities for more market growth. However, restrictive government regulations are expected to impede business growth.

Segmentation

The global market for chronic obstructive pulmonary disease (COPD) is segmented into a type of COPD, type of treatment, end-user, and region.

The global demand for chronic obstructive pulmonary disease (COPD) was divided into emphysema and chronic bronchitis, based on type COPD.

The global market for chronic obstructive pulmonary disease (COPD) has been segmented into drugs, surgery, and oxygen therapy, by treatment. The drugs group is further segmented into the bronchodilator monotherapy and anti-inflammatory products. Bronchodilator monotherapy is further sub-segmented into short-acting beta2-agonists (SABAs), long-acting beta2-agonists (LABAs), and anticholinergic agents. The sub-segment of anti-inflammatory drugs is further known as oral & inhaled corticosteroids, and anti-leukotrienes. The surgery segment is sub-segmented into surgery for the reduction of lung volume (LVRS), lung transplantation, bullectomy, and others.

Based on end-users, the global demand for chronic obstructive pulmonary disease (COPD) has been segmented into hospitals and clinics, home care facilities, and others.

Regionally, the global chronic obstructive pulmonary disease (COPD) market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is projected to capture a substantial share of the global market for chronic obstructive pulmonary disease (COPD) in the forecast period due to the highly advanced healthcare system and growing cases of chronic obstructive pulmonary disease (COPD) in the region. COPD, for example, is the leading cause of death in the United States, affecting 16 million Americans. Emphysema and chronic bronchitis are the two most severe forms of COPD. More than 8.9 million Americans Reliable Source were diagnosed with chronic bronchitis in 2016, and almost 75% of cases included people over the age of 45.

Europe is projected to be second-largest in the global market for chronic obstructive pulmonary disease (COPD) due to its well-developed market.

The Asia Pacific is projected to be the fastest-growing regional market due to the high number of patients suffering from COPD and the increasing prevalence of respiratory diseases.

The market for chronic obstructive pulmonary disease (COPD) in the Middle East and Africa is projected to rise gradually due to the growth of the healthcare infrastructure.

Key Players

Abbott Laboratories (US), Almirall (Spain), Astellas Pharma (Japan), AstraZeneca (UK), Boehringer Ingelheim (Germany), Circassia Pharmaceuticals (UK), GlaxoSmithKline (UK), Novartis AG (Switzerland), Pfizer, Inc. (US), and Teva Pharmaceutical Industries Ltd (Israel) are some of the key players operating in the global chronic obstructive pulmonary disease (COPD) market.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/chronic-obstructive-pulmonary-disease-copd-market-1612

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

Aromatherapy Market - https://www.globenewswire.com/en/news-release/2019/07/26/1892131/0/en/Aromatherapy-Market-Projected-to-Garner-6-18-CAGR-by-2023-Non-Invasiveness-Nature-of-Treatment-to-Bolster-Aromatherapy-Industry-Growth.html

Venous Blood Collection Devices Market - https://www.globenewswire.com/en/news-release/2019/07/26/1892127/0/en/Venous-Blood-Collection-Devices-Market-Striking-a-CAGR-of-9-3-By-2023-Increasing-Disposable-Income-Has-Been-Playing-a-Key-Role-in-Influencing-the-Global-Venous-Blood-Collection-Dev.html

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Location: New York, NY, USA

Comments

Post a Comment

Popular posts from this blog

Digital Pathology Market Research, Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2028

Image
  The growing number of innovations in the areas of pathology would further increase the size of the market to a great deal, in the next six years. According to MRFR, the Digital Pathology Market is expected to register a CAGR of 6.5% over the review period from 2021 to 2028 and expected to reach USD 1.4 Billion by 2028. Digital Pathology or Computational Pathology leverages completely new perceptions through data analysis, enabling pathologists to consult on treatment options. The rapidly evolving pathology sector is a key element of modern diagnostic practices. There have been several innovations and widespread adoption of digital pathology. It has long been realized that the traditional histopathology is inefficient as it exposes samples to various handlers, increasing the scope for human error. The digital pathology, on the other hand, eliminates the risk factors, while also providing the pathologist with the necessary images and clinical information to generate the most a...
Read more

Structural Heart Devices Market Size, Key Player Revenue, SWOT, PEST & Porter’s Analysis Till 2027

Image
Structural heart diseases   are problems associated with the valves or tissues of the heart. These diseases may be congenital or might be acquired later in life. Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others. As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period. The  structural heart devices market  is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to pro...
Read more

Anal Fissure Treatment Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2030

Image
  The global  anal fissure treatment market  is expected to rise and touch a valuation of USD 2,526.5 million by 2023, at a 7.6% CAGR during the forecast period. Anal fissures are small tears near the mucosal lining of the anus. Deeper cuts may take a combination of oral and topical medicine to alleviate the pain. The anal fissure treatment market is expected to thrive owing to the booming pediatric and geriatric patient pool. Advances in technology coupled with various treatment options is likely to lead to a windfall for the market over the forecast period. High incidence of constipation is predicted to drive the need for anal fissure treatments. This is backed by vulnerability of the elderly which find it difficult to pass stools properly. According to the American Gastroenterological, nearly 33% of Americans above 60 experience the condition. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3841 Unhealthy lifestyles adopted by pat...
Read more